Related Experiment Video
Updated: Feb 25, 2026

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
Published on: August 12, 2017
The DC1 conundrum: Do type I dendritic cells make or break allograft tolerance?
Ivana R Shen1, Shareni Jeyamogan2, Rebecca T L Jones1
1Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Type 1 conventional dendritic cells (DC1s) show a dual role in solid organ transplantation (SOT) tolerance. Emerging research highlights their potential as a novel cellular therapy for SOT, improving allograft survival without immunosuppression.
Area of Science:
- Immunology
- Transplantation Biology
- Cellular Therapy
Background:
- Solid organ transplantation (SOT) aims for long-term allograft survival without immunosuppression through immunological tolerance.
- Type 1 conventional dendritic cells (DC1s) are crucial for self-tolerance and have a complex role in allo-tolerance.
- Previous research primarily focused on monocyte-derived dendritic cells (moDCs) for tolerance induction.
Purpose of the Study:
- To review the dual role of DC1s in promoting and hindering allo-tolerance in SOT.
- To explore the impact of tissue microenvironment and cellular interactions on DC1 function.
- To discuss the potential of DC1s as a novel cellular therapy for SOT.
Main Methods:
- Review of existing literature on DC1 biology and function in transplantation.
- Analysis of recent advances in dendritic cell research and ontogeny.
- Examination of early-phase clinical trial data for DC-based cellular therapies in SOT.
Main Results:
- DC1s exhibit context-dependent functions, influencing both tolerance and rejection in SOT.
- Tissue microenvironment, antigen load, and cellular crosstalk modulate DC1 activity.
- Early clinical trials show promising safety and efficacy for tolerogenic DC therapy in SOT.
Conclusions:
- DC1s possess a subset-specific, tolerogenic capacity relevant to SOT.
- Understanding the complex functions of DC1s is key to developing effective cellular therapies.
- DC1-based cellular therapy represents a promising avenue for improving SOT outcomes.
Related Concept Videos
Cell-mediated Immune Responses
Special Features of Adaptive Immunity
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

